Raffaele Colombo, Associate Director of Medicinal Chemistry at Zymeworks, posted on X, about recent paper he and his colleagues co-authored:
“Honored and excited to be speaking at AACR25 educational session on “Next generation ADCs” this Saturday alongside Elisabeth de Vries and Josh Drago
For a great pre-read, check out our recent Cancer Discovery review (now free access!!!)
Title: The Journey of Antibody–Drug Conjugates: Lessons Learned from 40 Years of Development
Authors: Raffaele Colombo, Paolo Tarantino, et al.
Journal: Cancer Discovery, 2024 November
More posts featuring AACR25.
